Drugs / Therapeutic hepatitis B vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03038802 | Mar 2026 → Mar 2027 expected | chronic hepatitis B virus infection | Vaxine Pty Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Therapeutic hepatitis B vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03038802 ↗ |
| Modality | Vaccine | “experimental therapeutic hepatitis B vaccine” NCT03038802 ↗ |
| Route | Intramuscular | “regular intramuscular injections of the experimental therapeutic hepatitis B vaccine” NCT03038802 ↗ |